Federica Barbaglio

Via Olgettina 58
Milan, 20132, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

HS1 loss drives cytoskeletal dysregulation and reduces sensitivity to BTK inhibition in chronic lymphocytic leukemia.

HS1 loss drives cytoskeletal dysregulation and reduces sensitivity to BTK inhibition in chronic lymphocytic leukemia.

Journal: Journal of leukocyte biology

Published: February 04, 2026

A 3D lymph node model for chronic lymphocytic leukaemia recapitulates microenvironmental features and drug response in vitro.

A 3D lymph node model for chronic lymphocytic leukaemia recapitulates microenvironmental features and drug response in vitro.

Journal: Disease models & mechanisms

Published: October 30, 2025

A 3D lymph node model for chronic lymphocytic leukaemia recapitulates microenvironmental features and drug response in vitro.

A 3D lymph node model for chronic lymphocytic leukaemia recapitulates microenvironmental features and drug response in vitro.

Journal: Disease models & mechanisms

Published: October 30, 2025

Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro.

Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro.

Journal: Cell reports methods

Published: January 02, 2025

The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia.

The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia.

Journal: Blood cancer journal

Published: June 19, 2024

The Nanomechanical Properties of CLL Cells Are Linked to the Actin Cytoskeleton and Are a Potential Target of BTK Inhibitors.

The Nanomechanical Properties of CLL Cells Are Linked to the Actin Cytoskeleton and Are a Potential Target of BTK Inhibitors.

Journal: HemaSphere

Published: December 29, 2022

PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target.

PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target.

Journal: Journal of cellular and molecular medicine

Published: December 05, 2022

Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system.

Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system.

Journal: STAR protocols

Published: August 22, 2022

Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia.

Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma

Published: March 08, 2022

3D-STED Super-Resolution Microscopy Reveals Distinct Nanoscale Organization of the Hematopoietic Cell-Specific Lyn Substrate-1 (HS1) in Normal and Leukemic B Cells.

3D-STED Super-Resolution Microscopy Reveals Distinct Nanoscale Organization of the Hematopoietic Cell-Specific Lyn Substrate-1 (HS1) in Normal and Leukemic B Cells.

Journal: Frontiers in cell and developmental biology

Published: January 19, 2021

3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia Cells.

3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia Cells.

Journal: Frontiers in immunology

Published: December 09, 2020

Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents.

Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents.

Journal: Haematologica

Published: January 28, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026